MANAGEMENT OF DUSHEEVISHAJANYA DADRU KUSHTHA W.S.R. TO DERMATOPHYTOSIS THROUGH GANDEERIKADYA TAILA AND MARICHADYA TAILA WITH ARAGWADHADI KWATHA

RANDOMISED COMPARATIVE CLINICAL STUDY TO EVALUATE THE EFFICACY OF GANDEERIKADYA TAILA AND MARICHADYA TAILA WITH ARAGWADHADI KWATHA IN THE MANAGEMENT OF DUSHEEVISHAJANYA DADRU KUSHTHA W.S.R. TO DERMATOPHYTOSIS - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/03/106145

Enrollment

Registered

2026-03-13

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L00-L99- Diseases of the skin and subcutaneous tissue

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Individuals who voluntarily agree to participate in the clinical trial. 2. Male or female patients aged between 18 and 60 years. 3. Patients presenting with clinical signs and symptoms of Dushivishajanya Dadru Kustha w.s.r to Dermatophytosis 4. Patient with chronicity of illness less than 5 years.

Exclusion criteria

Exclusion criteria: 1. Individuals below the age of 18 years and above 60 years. 2. Patients with co-morbid conditions such as uncontrolled hypertension, diabetes mellitus, HIV, malignancies or other serious systemic disorders. 3. Patients with other dermatological disorders like eczema or those presenting with secondary bacterial skin infections. 4. Individuals with a history of the condition persisting for more than five years. 5. Patients with long term history of steroid and cytotoxic treatment. 6. Individuals who have participated in another clinical trial within the past six months. 7. Patients diagnosed with hyperlipidemia (high cholesterol levels). 8. Pregnant or lactating women.

Design outcomes

Primary

Measure	Time frame
The primary outcome of the study will be relief in Kandu (itching) at the end of the treatment period.Timepoint: 30 Days	—

Secondary

Measure	Time frame
Secondary outcomes will assess changes in both subjective and objective parameters, including Kandu (itching), Raga (redness/erythema), Pidika (skin eruptions) and Utasannamandala (raised circular lesions).Timepoint: 30 Days	—

Countries

India

Contacts

Public ContactPappu Lal Sharma

Madan Mohan Malviya government ayurved college

2021sbajiya1@gmail.com9079732500

Outcome results